Principal Financial Group Inc. Reduces Position in USANA Health Sciences, Inc. (NYSE:USNA)

Principal Financial Group Inc. trimmed its position in shares of USANA Health Sciences, Inc. (NYSE:USNA) by 4.4% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 52,123 shares of the company’s stock after selling 2,417 shares during the quarter. Principal Financial Group Inc.’s holdings in USANA Health Sciences were worth $1,977,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. American Century Companies Inc. boosted its stake in shares of USANA Health Sciences by 12.3% during the second quarter. American Century Companies Inc. now owns 159,782 shares of the company’s stock valued at $7,229,000 after purchasing an additional 17,460 shares during the period. Assenagon Asset Management S.A. lifted its holdings in USANA Health Sciences by 13.5% during the 3rd quarter. Assenagon Asset Management S.A. now owns 124,008 shares of the company’s stock valued at $4,702,000 after buying an additional 14,756 shares in the last quarter. Allspring Global Investments Holdings LLC boosted its position in USANA Health Sciences by 14,068.2% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 38,821 shares of the company’s stock valued at $1,472,000 after buying an additional 38,547 shares during the period. Barclays PLC grew its stake in USANA Health Sciences by 111.9% in the 3rd quarter. Barclays PLC now owns 27,737 shares of the company’s stock worth $1,052,000 after acquiring an additional 14,647 shares in the last quarter. Finally, State Street Corp increased its position in shares of USANA Health Sciences by 0.6% during the third quarter. State Street Corp now owns 435,164 shares of the company’s stock worth $16,501,000 after acquiring an additional 2,782 shares during the period. Institutional investors own 54.25% of the company’s stock.

USANA Health Sciences Trading Down 0.6 %

Shares of NYSE USNA opened at $36.17 on Friday. USANA Health Sciences, Inc. has a 12-month low of $31.44 and a 12-month high of $52.75. The stock’s fifty day simple moving average is $37.86 and its two-hundred day simple moving average is $39.59. The stock has a market capitalization of $689.40 million, a PE ratio of 12.78, a price-to-earnings-growth ratio of 1.25 and a beta of 0.89.

USANA Health Sciences (NYSE:USNA) last issued its quarterly earnings data on Tuesday, October 22nd. The company reported $0.56 earnings per share for the quarter, beating analysts’ consensus estimates of $0.49 by $0.07. The company had revenue of $200.22 million for the quarter, compared to the consensus estimate of $208.45 million. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. During the same quarter last year, the company earned $0.59 earnings per share. On average, equities analysts predict that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current fiscal year.

Insider Buying and Selling

In other USANA Health Sciences news, Director Gilbert A. Fuller sold 675 shares of the business’s stock in a transaction dated Monday, November 4th. The stock was sold at an average price of $37.71, for a total transaction of $25,454.25. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. 0.33% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several research analysts have commented on USNA shares. DA Davidson raised their price objective on USANA Health Sciences from $35.00 to $38.00 and gave the stock a “neutral” rating in a report on Thursday. StockNews.com upgraded USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a report on Saturday, December 28th.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.